Regeneron Pharmaceuticals, Inc.

ROYAL LONDON ASSET MANAGEMENT LTD REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

4,220

Value ($000)

3,257

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	3,257	0.0%	4,220	12/31/2025
2025 Q3	11/13/2025	2,534	0.0%	4,507	9/30/2025
2025 Q2	8/14/2025	24,450	0.1%	46,571	6/30/2025
2025 Q1	5/13/2025	31,478	0.1%	49,632	3/31/2025
2024 Q4	2/11/2025	31,402	0.1%	44,084	12/31/2024
2024 Q3	11/14/2024	45,913	0.1%	43,675	9/30/2024
2024 Q2	8/7/2024	44,693	0.1%	42,523	6/30/2024
2024 Q1	5/14/2024	39,520	0.1%	41,060	3/31/2024
2023 Q4	3/1/2024	36,580	0.1%	41,649	12/31/2023
2023 Q3	11/14/2023	33,395	0.1%	40,581	9/30/2023
2023 Q2	8/11/2023	27,983	0.1%	38,929	6/30/2023
2023 Q1	5/15/2023	30,154	0.1%	36,698	3/31/2023
2022 Q4	2/9/2023	26,589	0.1%	36,847	12/31/2022
2022 Q3	11/14/2022	24,145	0.1%	35,023	9/30/2022
2022 Q2	9/6/2022	21,479	0.1%	36,328	6/30/2022
2022 Q1	9/6/2022	25,164	0.1%	36,012	3/31/2022
2021 Q4	10/18/2022	21,596	0.1%	34,182	12/31/2021
2021 Q3	10/18/2022	21,041	0.1%	34,784	9/30/2021
2021 Q2	10/18/2022	19,149	0.1%	34,272	6/30/2021
2021 Q1	10/17/2022	17,100	0.1%	36,130	3/31/2021
2020 Q4	1/29/2021	16,965	0.1%	35,140	12/31/2020
2020 Q3	11/4/2020	21,468	0.1%	37,411	9/30/2020
2020 Q2	7/31/2020	22,867	0.2%	37,443	6/30/2020
2020 Q1	5/1/2020	15,013	0.1%	31,721	3/31/2020
2019 Q4	2/5/2020	11,912	0.1%	31,864	12/31/2019
2014 Q1	5/21/2014	5,254	0.1%	18,031	3/31/2014
2013 Q4	1/27/2014	5,007	0.1%	18,247	12/31/2013